Correlation Between Medigen Biotechnology and Jia Jie

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medigen Biotechnology and Jia Jie at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medigen Biotechnology and Jia Jie into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medigen Biotechnology and Jia Jie Biomedical, you can compare the effects of market volatilities on Medigen Biotechnology and Jia Jie and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medigen Biotechnology with a short position of Jia Jie. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medigen Biotechnology and Jia Jie.

Diversification Opportunities for Medigen Biotechnology and Jia Jie

0.3
  Correlation Coefficient

Weak diversification

The 3 months correlation between Medigen and Jia is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Medigen Biotechnology and Jia Jie Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jia Jie Biomedical and Medigen Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medigen Biotechnology are associated (or correlated) with Jia Jie. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jia Jie Biomedical has no effect on the direction of Medigen Biotechnology i.e., Medigen Biotechnology and Jia Jie go up and down completely randomly.

Pair Corralation between Medigen Biotechnology and Jia Jie

Assuming the 90 days trading horizon Medigen Biotechnology is expected to generate 7.58 times less return on investment than Jia Jie. But when comparing it to its historical volatility, Medigen Biotechnology is 1.21 times less risky than Jia Jie. It trades about 0.02 of its potential returns per unit of risk. Jia Jie Biomedical is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  2,045  in Jia Jie Biomedical on November 28, 2024 and sell it today you would earn a total of  135.00  from holding Jia Jie Biomedical or generate 6.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy94.44%
ValuesDaily Returns

Medigen Biotechnology  vs.  Jia Jie Biomedical

 Performance 
       Timeline  
Medigen Biotechnology 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Medigen Biotechnology are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Medigen Biotechnology may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Jia Jie Biomedical 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Jia Jie Biomedical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Medigen Biotechnology and Jia Jie Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medigen Biotechnology and Jia Jie

The main advantage of trading using opposite Medigen Biotechnology and Jia Jie positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medigen Biotechnology position performs unexpectedly, Jia Jie can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jia Jie will offset losses from the drop in Jia Jie's long position.
The idea behind Medigen Biotechnology and Jia Jie Biomedical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments